Mesalazine for the treatment of inflammatory bowel disease

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.12, 2013-08, pp. : 1669-1678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiopurine Treatment in Inflammatory Bowel Disease

By Gardiner Sharon J.

Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. : 803-804

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease

By Schwab M. Klotz U.

Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. : 723-751

Adis International

Access to resources Recommend Favorite

Treatment of Inflammatory Bowel Disease in the Elderly: An Update

By Pardi D.S. Loftus Jr E.V. Camilleri M.

Drugs & Aging, Vol. 19, Iss. 5, 2002-05 ,pp. : 355-363

Adis International

Access to resources Recommend Favorite

The use of tacrolimus in the treatment of inflammatory bowel disease

By Chow Dorothy KL Leong Rupert WL

Expert Opinion on Drug Safety, Vol. 6, Iss. 5, 2007-09 ,pp. : 479-485

Informa Healthcare

Access to resources Recommend Favorite

Multiparticulate Systems in the Treatment of Inflammatory Bowel Disease

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 137-144

Bentham Science Publishers

Access to resources Recommend Favorite